|
Mr. Schultz joined Clinical Data in October 2005. He was previously Vice President, Business Development of Pathway Diagnostics Corporation where he was responsible for the development of biomarker diagnostics business opportunities and out-licensing activities. Prior to Pathway Diagnostics, Mr. Schultz headed the Life Sciences Business Development activities at the Office of Intellectual Property Administration at UCLA, and prior to that was Director of Business Development at Specialty Laboratories where he spearheaded licensing activities. Mr. Schultz also has extensive experience in the clinical diagnostics market including serving as General Manager for the ImmunoSystems’ Division of BioChem Pharma (now Shire Pharmaceuticals) as well as positions at Sigma-Aldrich Corp., Isolab Inc. (now Perkin Elmer) and Mallinckrodt’s Forma Scientific Division (now Thermo Electron). Mr. Schultz holds a B.S. degree from Washington State University and a M.B.A. from The Garvin School of International Management in Glendale, Arizona. | 